IMPACT FACTOR 5.863 an Open Access Journal by MDPI
Anticancer Compounds in Medicinal Plants
Guest Editors: Message from the Guest Editors
Prof. Paulo Santos Cancer, in its multiple forms, is presently one of the leading Centro de Química - Vila Real, causes of death in both developing and developed Universidade de Trás-os-Montes countries, and it has become a major health problem and e Alto Douro, 5001-801 Vila Real, Portugal burden for most public health care systems worldwide. [email protected] Medicinal plants, which have made an important Prof. Dr. Lillian Barros contribution to the collection of compounds that are now Centro de Investigação de at our disposal for cancer therapy, constitute a reservoir of Montanha (CIMO), Instituto natural products able to provide new molecules with Politécnico de Bragança, Campus de Santa Apolónia, anticancer activity and new molecular frameworks capable 5300-253 Bragança, Portugal of inspiring the design of derivatives with improved [email protected] therapeutic ability.
This Special Issue invites researchers to contribute original research or review articles. The contributions include the Deadline for manuscript submissions: discovery of new compounds, the in vitro and in vivo 15 November 2021 assessment of the anticancer properties of compounds derived from medicinal plants, as well as the elucidation of their mechanisms of action and the design of derivatives with improved efficacy.
mdpi.com/si/49948 SpeciaIslsue IMPACT FACTOR 5.863 an Open Access Journal by MDPI
Editor-in-Chief Message from the Editor-in-Chief
Dr. Jean Jacques Vanden Because of your expertise in the field of drug sciences, I Eynde kindly invite you to consider publishing your current work, Formerly head of the Department in the form of a research article or a review, in the open of Organic Chemistry (FS), University of Mons-UMONS, 7000 access electronic journal Pharmaceuticals. Mons, Belgium Pharmaceuticals is characterized by an active editorial board and a dynamic editorial staff. Manuscripts are peer- reviewed and a final decision is provided to authors within 4–6 weeks a er submission. Papers are published on the web immediately a er acceptance. For details on the submission process or any other matter, please do not hesitate to contact us.
We hope to handle your contribution to Pharmaceuticals soon.
Author Benefits
Open Access:— free for readers, with article processing charges (APC) paid by authors or their institutions. High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases. Journal Rank: JCR - Q1 (Pharmacology & Pharmacy) / CiteScore - Q2 (Pharmaceutical Science)
Contact Us
Pharmaceuticals Tel: +41 61 683 77 34 mdpi.com/journal/pharmaceuticals MDPI, St. Alban-Anlage 66 Fax: +41 61 302 89 18 [email protected] 4052 Basel, Switzerland www.mdpi.com